Disclosures for "RNAi Therapy in ATTRv Amyloidosis with Polyneuropathy (HELIOS-A): Patient-reported Experiences and Preferences"
-
Dr. Gonzalez Duarte has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Anylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
-
Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer.
-
Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pfizer. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Dr. Galan Davila has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for pfizer. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sobi. The institution of Dr. Galan Davila has received research support from Alnylam.
-
John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio.
-
Dr. Bender has received personal compensation for serving as an employee of Alnylam Pharmaceuticals, Inc.. Dr. Bender has received personal compensation for serving as an employee of Boehringer Ingelheim Pharmaceuticals, Inc.. Dr. Bender has stock in Alnylam Pharmaceuticals, Inc..
-
Dr. Jain has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Jain has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Jain has stock in Alnylam Pharmaceuticals.
-
Mr. Kumar has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Mr. Kumar has stock in Alnylam Pharmaceuticals.
-
Dr. Capocelli has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Capocelli has stock in Alnylam Pharmaceuticals.
-
Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.